Princess Anna Mazowiecka Hospital Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2017
NCT03087149
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Princess Anna Mazowiecka Hospital, Warsaw, Poland

Active Ingredients

Drugs in Other Trials (1)

vitamin d3 (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1